Mekenna Mroskey
Nurse Practitioner · Walnut Creek, CANPI 1134517303
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,422, 4.0 times the $359 reported in 2021.
Across 70 payments — averaging $28.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$190
- AstraZeneca$156
- Galderma Laboratories, L.p.$114
- AbbVie$113
- Lilly USA, LLC$112
- Incyte Corporation$106
- plus $1K from 28 others
What the payments were for
- Food & beverage$1,87095%
- Education$965%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 7 | $190 |
| AstraZeneca | 6 | $156 |
| Galderma Laboratories, L.p. | 1 | $114 |
| AbbVie | 3 | $113 |
| Lilly USA, LLC | 2 | $112 |
| Incyte Corporation | 4 | $106 |
| Johnson & Johnson(2 entities) | 4 | $100 |
| Daiichi Sankyo Inc. | 4 | $93 |
| Bristol Myers Squibb | 3 | $83 |
| Genentech USA, Inc. | 3 | $77 |
| Pfizer | 3 | $73 |
| Stemline Therapeutics Inc. | 1 | $56 |
| Novartis | 3 | $54 |
| Beone Medicines USA, Inc. | 2 | $49 |
| Teleflex LLC | 1 | $48 |
| Eisai Inc. | 2 | $43 |
| Tersera Therapeutics LLC | 2 | $41 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $41 |
| Exelixis Inc. | 1 | $40 |
| Pharmaessentia USA Corporation | 2 | $40 |
| Iovance Biotherapeutics, Inc. | 1 | $35 |
| Array Biopharma Inc | 1 | $35 |
| GSK | 1 | $32 |
| Syndax Pharmaceuticals, Inc. | 1 | $30 |
| ADC Therapeutics America, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Sobi, Inc | 1 | $23 |
| Fennec Pharmaceuticals, Inc. | 1 | $22 |
| Legend Biotech USA Inc. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Springworks Therapeutics, Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Napo Pharmaceuticals Inc | 1 | $15 |
How this compares
$1,966 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Walnut Creek
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.